[
    {
        "file_name": "IbioInc_20200313_8-K_EX-10.1_12052678_EX-10.1_Development Agreement.txt",
        "perturbation": [
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "Agreement Administration. The Agreement administrator for each Party must be contacted regarding all business-related matters, including any proposed modifications to this Agreement, the phasing plan of the SOW, for each project. An iBio Agreement Administrator is to be named on or before the Effective Date of the First Phase of the SOW. A CC-Pharming Agreement Administrator is to be named on or before the Effective Date of the First Phase of the SOW.",
                "changed_text": "Agreement Administration. The Project Lead for each Party must be contacted regarding all business-related matters, including any proposed modifications to this Agreement, the phasing plan of the SOW, for each project. An iBio Agreement Administrator is to be named on or before the Effective Date of the First Phase of the SOW. A CC-Pharming Agreement Supervisor is to be named on or before the Effective Date of the First Phase of the SOW.",
                "explanation": "The terms 'Project Lead', 'Agreement Administrator' and 'Agreement Supervisor' are used interchangeably without clear definitions. This can lead to confusion about who is responsible for specific tasks and who to contact for different matters, creating uncertainty in enforcement.",
                "location": "2.2"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "The Parties shall share equally in the costs of patent protection for Joint Inventions.",
                "changed_text": "The Parties shall share proportionately in the costs of patent protection for Joint Developments.",
                "explanation": "Changing 'Joint Inventions' to 'Joint Developments' and 'equally' to 'proportionately' without defining 'developments' or 'proportionately' creates ambiguity. 'Joint Inventions' is a clearly defined term later in that same sentence. The modified term and allocation of cost is undefined.",
                "location": "4.2"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "Confidential Information must be identified as Confidential at the time of disclosure, and all material containing Confidential Information must have a restrictive marking. Any Confidential Information disclosed orally or visually must be summarized by the disclosing Party in writing and the writing must be provided to the receiving Party within twenty (20) days after the disclosure.",
                "changed_text": "Proprietary Information must be identified as Confidential at the time of disclosure, and all material containing Confidential Information must have a restrictive marking. Any Confidential Data disclosed orally or visually must be summarized by the disclosing Party in writing and the writing must be provided to the receiving Party within thirty (30) days after the disclosure.",
                "explanation": "The original text requires 'Confidential Information' to be identified as 'Confidential,' but the modified version introduces 'Proprietary Information' and 'Confidential Data', without clarifying if they are distinct from or equivalent to 'Confidential Information'. The time of summary is also modified from 20 days to 30 days without reason.",
                "location": "7.6"
            }
        ]
    }
]